Recovery Under Way, Pressure BioSciences Q2 Revenues Up 125 Percent | GenomeWeb

Continuing its way back from restructuring of its business at the end of 2008, Pressure BioSciences this week announced that revenues for the second quarter more than doubled to $270,381 from $120,184 in the year-ago period.

During the three months ended June 30, the company also installed 12 of its flagship Barocycler instruments, compared to seven during Q2 2008. Revenues from PBI's pressure cycling technology product and services accounted for $159,202, up from $117,698 in Q2 2008.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.